Skip to content

Australia logo

Main menu
    • Vision, Mission and Values
    • Reports and Resources
    • Diversity, Equity, Inclusion & Belonging
    • Reconciliation Action Plan
    • Environmental, Social & Governance
    • Global Executive Team
    • ANZ Leadership Team
  • Our Products
  • News
  • Join Our Team
  • Contact Us

Visit Organon's LinkedIn Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA

  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom

  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Our products

This page is intended to comply with Australian regulatory requirements only and is intended for use by consumers for the Consumer Medical Information (CMI), and healthcare professionals for the Product Information and CMI. This information is not medical advice and any information provided by this source and any medical questions should be discussed with a healthcare professional. Healthcare professionals can access additional information on some of the products listed below, from OrganonPro. Please note, registration is required.

ANTROQUORIL® betamethasone valerate
Product Information                             Consumer Medicine Information
ARCOXIA® etoricoxib
Product Information                             Consumer Medicine Information
ATOZET® ezetimibe/atorvastatin
Product Information                             Consumer Medicine Information
AVANZA® mirtazapine
Product Information                             Consumer Medicine Information
BRENZYS® etanercept
Product Information                             Consumer Medicine Information
CELESTONE -M® betamethasone valerate
Product Information                             Consumer Medicine Information
CELESTONE CHRONODOSE® betamethasone [acetate + sodium phosphate] injection
Product Information                             Consumer Medicine Information
COZAAR® losartan
Product Information                             Consumer Medicine Information
DIPROSONE® betamethasone dipropionate
Product Information                             Consumer Medicine Information
DIPROSONE OV® betamethasone dipropionate
Product Information                             Consumer Medicine Information
ELEUPHRAT® betamethasone dipropionate
Product Information                             Consumer Medicine Information
ELOCON® mometasone furoate
Product Information                             Consumer Medicine Information
ELONVA® corifollitropin alfa
Product Information                             Consumer Medicine Information
EZALO® ezetimibe and rosuvastatin (as calcium)
Product Information                             Consumer Medicine Information
EZETROL® ezetimibe
Product Information                             Consumer Medicine Information
FOSAMAX PLUS® alendronate sodium/colecalciferol
Product Information                             Consumer Medicine Information
HADLIMA® adalimumab
Product Information                             Consumer Medicine Information (PushTouch Auto-Injector)
                             Consumer Medicine Information (Pre-filled Syringe)
IMPLANON NXT® etonogestrel
Product Information                             Consumer Medicine Information
JADA System® intrauterine haemostatic suction catheter
Instructions for use
LIPEX® simvastatin
Product Information                             Consumer Medicine Information
LIVIAL® tibolone
Product Information                             Consumer Medicine Information
LUKAIR® montelukast
Product Information                             Consumer Medicine Information
MARVELON 28® ethinylestradiol/desogestrel
Product Information                             Consumer Medicine Information
MAXALT® rizatriptan benzoate
Product Information                             Consumer Medicine Information
MAXALT MIGRAINE RELIEF® rizatriptan benzoate
Product Information                                     Consumer Medicine Information
NASONEX® mometasone furoate monohydrate
Product Information                             Consumer Medicine Information
NOVASONE® mometasone furoate
Product Information                             Consumer Medicine Information
NUVARING® ethinylestradiol/etonogestrel
Product Information                             Consumer Medicine Information
OLMETEC® olmesartan medoxomil
Product Information                             Consumer Medicine Information
OLMETEC PLUS® olmesartan medoxomil/hydrochlorothiazide
Product Information                             Consumer Medicine Information
ORGALUTRAN® ganirelix
Product Information                             Consumer Medicine Information
PROPECIA® finasteride
Product Information                             Consumer Medicine Information
PUREGON® follitropin beta
Product Information                             Consumer Medicine Information
RENFLEXIS® infliximab
Product Information                             Consumer Medicine Information
RENITEC® enalapril maleate
Product Information                             Consumer Medicine Information
RENITEC PLUS® enalapril maleate/ hydrochlorothiazide
Product Information                             Consumer Medicine Information
RIZATRIPTAN® rizatriptan wafers 10 mg
Product Information                             Consumer Medicine Information
ROSUZET® ezetimibe/rosuvastatin
Product Information                             Consumer Medicine Information
SAPHRIS® asenapine maleate
Product Information                             Consumer Medicine Information
SEVIKAR® olmesartan medoxomil/ amlodipine besilate
Product Information                             Consumer Medicine Information
SEVIKAR HCT® olmesartan medoxomil/ amlodipine besilate/ hydrochlorothiazide
Product Information                             Consumer Medicine Information
SINEMET® carbidopa/levodopa
Product Information                             Consumer Medicine Information
SINEMET CR® carbidopa/levodopa
Product Information                             Consumer Medicine Information
SINGULAIR® montelukast sodium
Product Information                             Consumer Medicine Information
VYTORIN® ezetimibe/simvastatin
Product Information                             Consumer Medicine Information
XYVION® tibolone
Product Information                             Consumer Medicine Information
ZIENT® ezetimibe
Product Information                             Consumer Medicine Information
ZOCOR® simvastatin
Product Information                             Consumer Medicine Information

To report an Adverse Event or Product Quality Complaint, or if you have a Medical Information enquiry about a specific Organon product, please call/email the Organon Medical Information Team.

Call 1800 023 135 or email Contact Us – Welcome to Organon Pro OR dpoc.anz@organon.com

Monday – Friday: 9:00 am – 5:00 pm AEST

Connect with us on social

Linkedin icon Opens a new window
Australia logo
  • Cookie Policy
  • Forward looking statement
  • Privacy Policy
  • Terms of use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. The Organon Australia website is intended for an Australian audience only. AU-NON-110274. Date of preparation: April 2025.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept